Indolin-2-one compounds targeting thioredoxin reductase as potential anticancer drug leads

by Kaminska, K.K, Bertrand, H.C, Tajima, H, Stafford, W.C, Cheng, Q, Chen, W, Wells, G, Arner, E.S.J, Chew, E.-H
Published 2020

Identification of michael acceptor-centric pharmacophores with substituents that yield strong thioredoxin reductase inhibitory character correlated to antiproliferative activity

by Gan, F.-F., Kaminska, K.K., Yang, H., Liew, C.-Y., Leow, P.-C., So, C.-L., Tu, L.N.L., Roy, A., Yap, C.-W., Kang, T.-S., Chui, W.-K., Chew, E.-H.
Published 2014